This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Doudou Yan: Innovator in Dual-Drug Co-Delivery Systems
Introduction
Doudou Yan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of cancer treatments through advanced pharmaceutical technologies.
Latest Patents
Doudou Yan holds a patent for a dual-drug co-delivery system, which includes a preparation method and its applications. The patent, titled "Dual-drug co-delivery system, preparation method therefor and use thereof," describes a system that utilizes raw materials such as a block copolymer, Homoharringtonine, and Doxorubicin hydrochloride. This innovative system demonstrates a stronger killing effect on various hematologic tumors and solid tumor cells. It provides a feasible drug delivery mechanism for inhibiting tumor growth and treating leukemia, showcasing broad prospects for future applications.
Career Highlights
Doudou Yan is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and develops new medical technologies. His work has been instrumental in advancing the understanding and treatment of cancer, particularly through innovative drug delivery methods.
Collaborations
Doudou Yan collaborates with esteemed colleagues such as Haiyan Xu and Jie Meng. Their combined expertise contributes to the advancement of medical research and the development of effective treatment solutions.
Conclusion
Doudou Yan's contributions to the field of medical science, particularly through his dual-drug co-delivery system, highlight his role as an innovator in cancer treatment. His work not only enhances therapeutic efficacy but also paves the way for future advancements in drug delivery technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile